Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

A man's gray hair got darker and thicker after using a psoriasis drug.

Targeting IL-17 could help treat pattern hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

MMP-9 increase in hair follicles may lead to hair loss.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Understanding the genetics of alopecia areata could lead to better treatments.

Understanding molecular mediators can improve skin healing treatments.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Special cells can help regrow hair in alopecia areata.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Understanding and targeting specific molecules can help reduce scarring and promote scar-free healing.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Probiotic bacteria improved skin and hair health in aged mice.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.